CanTEST drug checking service extended
The ACT Government will continue to fund CanTEST Health and Drug Checking Service until June 2027, extending its current funding commitment by $1.8 million.
Since the service opened its doors in July 2022 under a 6-month pilot, the ACT Government has continued to extend its funding due to the beneficial results in harm minimisation that the service achieves.
In its first 22 months of operation, CanTEST tested more than 2,600 samples, with more than 10 per cent of samples being voluntarily discarded by clients following testing.
The service delivered more than 3,600 health and alcohol and drug interventions to individuals and groups in its first year, with some clients receiving multiple interventions in one visit.
CanTEST provides chemical analysis of drugs and pills to help users better understand the unknown and potentially dangerous substances in illicit drugs. It also provides access to drop-in nurse consultations offering general health, sexual health and mental health advice.
A range of drugs have been brought into the service for testing, including highly dangerous synthetic opioids, MDMA, heroin, methamphetamine, cocaine, ketamine and psychedelics. In many cases the substances tested were not what people expected them to be.
The service has also contributed to information about the drugs circulating in the Canberra community, which allows health services and the wider community to learn about and respond to dangerous substances earlier.
The ACT Government is committed to harm minimisation, in line with the National Drug Strategy 2016-2026 and the ACT Drug Strategy Action Plan 2022-2026.
CanTEST Health and Drug Checking Service is run by Directions Health Services in partnership with Pill Testing Australia and Canberra Alliance for Harm Minimisation and Advocacy.
Located on the ground floor of the City Community Health Centre at 1 Moore Street Civic, the free and confidential service is open every Thursday from 3pm – 6pm and Friday from 6pm – 9pm.
Quotes attributable to ACT Chief Minister, Andrew Barr:
“The additional $1.8 million of CanTEST funding until 2027 will continue to provide the Canberra community with reliable drug and pill testing services, helping individuals make informed choices and reduce the risks associated with illicit substances.
“Earlier this year, CanTEST issued a crucial community notice via social media after discovering synthetic opioids being checked – potentially saving lives. This incident highlights CanTEST’s crucial role in safeguarding our community and the need for extending funding.
The ACT continues to demonstrate its leadership as a progressive jurisdiction, and underscores our commitment to public health and safety, ensuring Canberra remains at the forefront of harm reduction efforts nationwide.”
